0001716567-17-000001.txt : 20170914 0001716567-17-000001.hdr.sgml : 20170914 20170913183534 ACCESSION NUMBER: 0001716567-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20170914 DATE AS OF CHANGE: 20170913 EFFECTIVENESS DATE: 20170914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hemostemix Inc. CENTRAL INDEX KEY: 0001716567 IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-294665 FILM NUMBER: 171084099 BUSINESS ADDRESS: STREET 1: BAY 1, 5220 DUNCAN AVENUE, PO BOX 10 CITY: BLACKFALDS STATE: A0 ZIP: T0M 0J0 BUSINESS PHONE: 403-340-9207 MAIL ADDRESS: STREET 1: BAY 1, 5220 DUNCAN AVENUE, PO BOX 10 CITY: BLACKFALDS STATE: A0 ZIP: T0M 0J0 D 1 primary_doc.xml X0708 D LIVE 0001716567 Hemostemix Inc. BAY 1, 5220 DUNCAN AVENUE, PO BOX 10 BLACKFALDS A0 ALBERTA, CANADA T0M 0J0 403-340-9207 ALBERTA, CANADA None None Corporation true 2014 Angus Jenkins 10 Evergreen Heath SW Calgary A0 ALBERTA, CANADA T2Y 4R3 Director David L. Wood 310, 16477 - 64 Avenue Surrey A1 BRITISH COLUMBIA, CANADA V3S 6V7 Director Don Friesen 143 Pumpmeadow Place SW Calgary A0 ALBERTA, CANADA T2V 5H4 Director David Berman 33 Michael Court Thornhill A6 ONTARIO, CANADA L4J 8E9 Executive Officer Chief Financial Officer Ina Sarel Yoseph Haglili 7 Ramat Gan L3 ISRAEL 5241611 Executive Officer VP, Research and Development Kyle Makofka Bay 1, 5220 Duncan Avenue Blackfalds A0 ALBERTA, CANADA T0M 0J0 Executive Officer Chief Restructuring Officer Biotechnology Decline to Disclose 06c false 2017-08-25 false true true false 0 132071 0 132071 false 2 0 0 0 false Hemostemix Inc. /s/ Kyle Makofka Kyle Makofka Chief Restructuring Officer 2017-09-07